{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-329622","form_type":"8-K","ticker":"LNTH","cik":"0001521036","company_name":"Lantheus Holdings, Inc.","filed_at":"2026-08-03T12:37:46+00:00","discovered_at":"2026-08-03T12:40:00.403928+00:00","generated_at":"2026-08-03T12:40:06.738509+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":1.0,"calibrated_materiality_score":1.0,"confidence":"high","headline":"Curium to acquire Lantheus for up to $114.50/share ($8.0B); 38% premium to 60-day VWAP","bullets":["Total consideration up to $114.50/share: $102.50 cash at closing plus up to $12.00 in CVRs tied to commercial milestones through 2030.","Aggregate transaction value up to $8.0B; premiums of 38% (60-day VWAP), 29% (30-day VWAP), and 21% (unaffected close).","Lantheus Board unanimously approved; transaction expected to close in first half of 2027, subject to shareholder and regulatory approvals.","Lantheus pauses CEO search, suspends FY2026 guidance, and will not host Q2 2026 earnings call due to pending merger.","Combined company will serve oncology, neurology, and cardiology patients across more than 70 countries."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-329622","json":"https://secwatch.observer/filing/0001193125-26-329622.json","markdown":"https://secwatch.observer/filing/0001193125-26-329622.md","text":"https://secwatch.observer/filing/0001193125-26-329622.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1521036/000119312526329622/0001193125-26-329622-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1521036/000119312526329622/d148563d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T12:40:06.738509+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}